-
1
-
-
0028871474
-
Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectively in the mesolimbic dopaminergic system
-
Andersson J.L., Nomikos G.G., Marcus M., Hertel P., Mathé J.M., Svensson T.H. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectively in the mesolimbic dopaminergic system. Naunyn Schmiedebergs Arch Pharmacol. 352:1995;374-385.
-
(1995)
Naunyn Schmiedebergs Arch Pharmacol
, vol.352
, pp. 374-385
-
-
Andersson, J.L.1
Nomikos, G.G.2
Marcus, M.3
Hertel, P.4
Mathé, J.M.5
Svensson, T.H.6
-
2
-
-
0019943797
-
Pharmacological specificity of conditioned avoidance response inhibition in rats: Inhibition by neuroleptics and correlation to dopamine receptor blockade
-
Arnt J. Pharmacological specificity of conditioned avoidance response inhibition in rats Inhibition by neuroleptics and correlation to dopamine receptor blockade . Acta Pharmacol Toxicol. 51:1982;321-329.
-
(1982)
Acta Pharmacol Toxicol
, vol.51
, pp. 321-329
-
-
Arnt, J.1
-
4
-
-
0001875379
-
Drugs and the treatment of psychiatric disorders: Psychosis and anxiety
-
In: Molinoff PB, Ruddon RW, Goodman Gilman A, editors New York: McGraw-Hill
-
Baldessarini R (1996): Drugs and the treatment of psychiatric disorders: Psychosis and anxiety. In: Molinoff PB, Ruddon RW, Goodman Gilman A, editors. Goodman & Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill, pp 399-430.
-
(1996)
Goodman & Gilman's the Pharmacological Basis of Therapeutics
, pp. 399-430
-
-
Baldessarini, R.1
-
5
-
-
0028789388
-
Risperidone in the treatment of negative symptoms of schizophrenia: A meta-analysis
-
Carman J., Peuskens J., Vangeneugden A. Risperidone in the treatment of negative symptoms of schizophrenia A meta-analysis . Int Clin Psychopharmacol. 10:1995;207-213.
-
(1995)
Int Clin Psychopharmacol
, vol.10
, pp. 207-213
-
-
Carman, J.1
Peuskens, J.2
Vangeneugden, A.3
-
6
-
-
0002581944
-
Pharmacodynamic basis for the use of chlorpromazine in psychiatry
-
Courvoisier S. Pharmacodynamic basis for the use of chlorpromazine in psychiatry. J Clin Exp Psychopathol Q Rev Psychiat Neurol. 17:1956;25-37.
-
(1956)
J Clin Exp Psychopathol Q Rev Psychiat Neurol
, vol.17
, pp. 25-37
-
-
Courvoisier, S.1
-
7
-
-
0002329151
-
Nouveaux aspects expérimenteaux de l'activité centrale des dérivés de la phenothiazine
-
S. Garattini, & V. Ghetti. Amsterdam: Elsevier
-
Courvoisier S., Ducrot R., Julou L. Nouveaux aspects expérimenteaux de l'activité centrale des dérivés de la phenothiazine. Garattini S., Ghetti V. Psychotropic Drugs. 1957;373-391 Elsevier, Amsterdam.
-
(1957)
Psychotropic Drugs
, pp. 373-391
-
-
Courvoisier, S.1
Ducrot, R.2
Julou, L.3
-
8
-
-
0017120689
-
Differential effects of neuroleptic and other psychotropic agents on acquisition of avoidance in rats
-
Davidson A.B., Weidley E. Differential effects of neuroleptic and other psychotropic agents on acquisition of avoidance in rats. Life Sci. 18:1976;1279-1284.
-
(1976)
Life Sci
, vol.18
, pp. 1279-1284
-
-
Davidson, A.B.1
Weidley, E.2
-
10
-
-
0027490544
-
Ritanserin, a selective 5-HT2/1C antagonist, and negative symptoms in schizophrenia: A placebo-controlled double-blind trial
-
Duinkerke S.J., Botter P.A., Jansen A.A.I., van Dongen P.A.M., van Haaften A.J., Boom A.J., et al. Ritanserin, a selective 5-HT2/1C antagonist, and negative symptoms in schizophrenia A placebo-controlled double-blind trial . Br J Psychiatry. 163:1993;451-455.
-
(1993)
Br J Psychiatry
, vol.163
, pp. 451-455
-
-
Duinkerke, S.J.1
Botter, P.A.2
Jansen, A.A.I.3
Van Dongen, P.A.M.4
Van Haaften, A.J.5
Boom, A.J.6
-
11
-
-
0024430178
-
D1- And D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics
-
Farde L., Wiesel F.A., Nordström A.-L., Sedvall G. D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology. 99:1989;S28-S31.
-
(1989)
Psychopharmacology
, vol.99
-
-
Farde, L.1
Wiesel, F.A.2
Nordström, A.-L.3
Sedvall, G.4
-
12
-
-
0019153602
-
Mesolimbic and mesocortical dopaminergic neurons are necessary for normal exploratory behavior in rats
-
Fink J.S., Smith G.P. Mesolimbic and mesocortical dopaminergic neurons are necessary for normal exploratory behavior in rats. Neurosci Lett. 17:1980;61-65.
-
(1980)
Neurosci Lett
, vol.17
, pp. 61-65
-
-
Fink, J.S.1
Smith, G.P.2
-
13
-
-
0028183017
-
VII International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)
-
Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., et al. VII International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev. 46:1994;157-203.
-
(1994)
Pharmacol Rev
, vol.46
, pp. 157-203
-
-
Hoyer, D.1
Clarke, D.E.2
Fozard, J.R.3
Hartig, P.R.4
Martin, G.R.5
Mylecharane, E.J.6
-
14
-
-
0023850460
-
Pharmacology of risperidone (R64766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties
-
Janssen P.A.J., Niemegeers C., Awouters F., Schellekens K.H.L., Megens A.A.H.P., Meert T.F. Pharmacology of risperidone (R64766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. J Pharmacol Exp Ther. 244:1988;685-693.
-
(1988)
J Pharmacol Exp Ther
, vol.244
, pp. 685-693
-
-
Janssen, P.A.J.1
Niemegeers, C.2
Awouters, F.3
Schellekens, K.H.L.4
Megens, A.A.H.P.5
Meert, T.F.6
-
15
-
-
0013887299
-
Is it possible to predict the clinical effects of neuroleptic drugs (major tranquilizers) from animal data? Part III: The subcutaneous and oral activity in rats and dogs of 56 neuroleptic drugs in the jumping box test
-
Janssen P.A.J., Niemegeers C., Schellekens K.H.L. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquilizers) from animal data? Part III The subcutaneous and oral activity in rats and dogs of 56 neuroleptic drugs in the jumping box test . Arzneimittel Forschung. 16:1966;339-346.
-
(1966)
Arzneimittel Forschung
, vol.16
, pp. 339-346
-
-
Janssen, P.A.J.1
Niemegeers, C.2
Schellekens, K.H.L.3
-
16
-
-
0023812652
-
Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine
-
Kane J., Honigfeld G., Singer J., Meltzer H.Y. Clozapine for the treatment-resistant schizophrenic A double-blind comparison with chlorpromazine . Arch Gen Psychiatry. 45:1988;789-796.
-
(1988)
Arch Gen Psychiatry
, vol.45
, pp. 789-796
-
-
Kane, J.1
Honigfeld, G.2
Singer, J.3
Meltzer, H.Y.4
-
17
-
-
0029988896
-
Serotonin-dopamine interaction and its relevance to schizophrenia
-
Kapur S., Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry. 153:1996;466-476.
-
(1996)
Am J Psychiatry
, vol.153
, pp. 466-476
-
-
Kapur, S.1
Remington, G.2
-
21
-
-
84951384024
-
A simplified method of evaluating dose-effect experiments
-
Litchfield J.T., Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther. 96:1949;99-113.
-
(1949)
J Pharmacol Exp Ther
, vol.96
, pp. 99-113
-
-
Litchfield, J.T.1
Wilcoxon, F.2
-
22
-
-
0024468417
-
Clinical studies on the mechanism of action of clozapine: The dopamine-serotonin hypothesis of schizophrenia
-
Meltzer H.Y. Clinical studies on the mechanism of action of clozapine The dopamine-serotonin hypothesis of schizophrenia . Psychopharmacology. 99:1989;S18-S27.
-
(1989)
Psychopharmacology
, vol.99
-
-
Meltzer, H.Y.1
-
23
-
-
0029197942
-
Role of serotonin in the action of atypical antipsychotic drugs
-
Meltzer H.Y. Role of serotonin in the action of atypical antipsychotic drugs. Clin Neurosci. 3:1995;64-75.
-
(1995)
Clin Neurosci
, vol.3
, pp. 64-75
-
-
Meltzer, H.Y.1
-
24
-
-
0002629884
-
Atypical antipsychotic drugs
-
F.E. Bloom, & D.J. Kupfer. New York: Raven Press
-
Meltzer H.Y. Atypical antipsychotic drugs. Bloom F.E., Kupfer D.J. Psychopharmacology The Fourth Generation of Progress . 1995;1277-1286 Raven Press, New York.
-
(1995)
Psychopharmacology: The Fourth Generation of Progress
, pp. 1277-1286
-
-
Meltzer, H.Y.1
-
25
-
-
0000143918
-
Antiparkinson drugs and neuroleptics
-
W.A. Himwich, Schadé J.P. Amsterdam: Elsevier
-
Morpurgo C. Antiparkinson drugs and neuroleptics. Himwich W.A., Schadé J.P. Progress in Brain Res. vol 16:1965;121-134 Elsevier, Amsterdam.
-
(1965)
Progress in Brain Res
, vol.16
, pp. 121-134
-
-
Morpurgo, C.1
-
27
-
-
0027988050
-
What makes atypical antipsychotics atypical? The case for serotonergic mechanisms of action
-
O'Neill M.F., Palacios J.M. What makes atypical antipsychotics atypical? The case for serotonergic mechanisms of action. Exp Opin Invest Drugs. 3:1994;1317-1321.
-
(1994)
Exp Opin Invest Drugs
, vol.3
, pp. 1317-1321
-
-
O'Neill, M.F.1
Palacios, J.M.2
-
28
-
-
0000888049
-
An analysis of chlorpromazine-induced suppression of the avoidance response
-
Ponsluns D. An analysis of chlorpromazine-induced suppression of the avoidance response. Psychopharmacology. 3:1962;361-373.
-
(1962)
Psychopharmacology
, vol.3
, pp. 361-373
-
-
Ponsluns, D.1
-
29
-
-
0029204824
-
New approaches to the drug treatment of schizophrenia
-
Reynolds G.P., Czudek C. New approaches to the drug treatment of schizophrenia. Adv Pharmacol. 32:1995;461-503.
-
(1995)
Adv Pharmacol
, vol.32
, pp. 461-503
-
-
Reynolds, G.P.1
Czudek, C.2
-
31
-
-
0022389268
-
The effects of clozapine on shuttle-box avoidance responding in rats: Comparisons with haloperidol and chlordiazepoxide
-
Sanger D.J. The effects of clozapine on shuttle-box avoidance responding in rats Comparisons with haloperidol and chlordiazepoxide . Pharmacol Biochem Behav. 23:1984;231-236.
-
(1984)
Pharmacol Biochem Behav
, vol.23
, pp. 231-236
-
-
Sanger, D.J.1
-
32
-
-
0026613672
-
2 receptors exert a state dependent regulation of dopaminergic function: Studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine
-
2 receptors exert a state dependent regulation of dopaminergic function Studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine . Eur J Pharmacol. 223:1992;65-74.
-
(1992)
Eur J Pharmacol
, vol.223
, pp. 65-74
-
-
Schmidt, C.J.1
Fadayel, G.M.2
Sullivan, C.K.3
Taylor, V.L.4
-
33
-
-
0027723207
-
Contribution of serotonin neurotoxins to understanding psychiatric disorders: The role of 5-HT2 receptors in schizophrenia and antipsychotic activity
-
Schmidt C.J., Kehne J.H., Carr A.A., Fadayel G.M., Humphreys T.M., Kettler H.J., et al. Contribution of serotonin neurotoxins to understanding psychiatric disorders The role of 5-HT2 receptors in schizophrenia and antipsychotic activity . Int Clin Psychopharmacol. 8:1993;25-32.
-
(1993)
Int Clin Psychopharmacol
, vol.8
, pp. 25-32
-
-
Schmidt, C.J.1
Kehne, J.H.2
Carr, A.A.3
Fadayel, G.M.4
Humphreys, T.M.5
Kettler, H.J.6
-
34
-
-
0003005889
-
Receptor selectivities of atypical neuroleptics
-
H.Y. Meltzer. New York: Raven Press
-
Seeman P. Receptor selectivities of atypical neuroleptics. Meltzer H.Y. Novel Antipsychotic Drugs. 1992;145-154 Raven Press, New York.
-
(1992)
Novel Antipsychotic Drugs
, pp. 145-154
-
-
Seeman, P.1
-
36
-
-
0028791321
-
DOI disruption of prepulse inhibition of startle in the rat is mediated by 5-HT2A and not by 5-HT2C receptors
-
Sipes T.E., Geyer M.A. DOI disruption of prepulse inhibition of startle in the rat is mediated by 5-HT2A and not by 5-HT2C receptors. Behav Pharmacol. 6:1995;839-842.
-
(1995)
Behav Pharmacol
, vol.6
, pp. 839-842
-
-
Sipes, T.E.1
Geyer, M.A.2
-
37
-
-
0015747180
-
An anatomy of schizophrenia?
-
Stevens J.R. An anatomy of schizophrenia? Arch Gen Psychiatry. 29:1973;177-189.
-
(1973)
Arch Gen Psychiatry
, vol.29
, pp. 177-189
-
-
Stevens, J.R.1
-
38
-
-
0027340586
-
2 receptor antagonist MDL 100,907 as a putative atypical antipsychotic: Behavioral, electrophysiological and neurochemical studies
-
2 receptor antagonist MDL 100,907 as a putative atypical antipsychotic Behavioral, electrophysiological and neurochemical studies . J Pharmacol Exp Ther. 266:1993;684-691.
-
(1993)
J Pharmacol Exp Ther
, vol.266
, pp. 684-691
-
-
Sörensen, S.M.1
Kehne, J.H.2
Fadayel, G.M.3
Humphreys, T.M.4
Ketteler, H.J.5
Sullivan, C.K.6
-
39
-
-
0001054442
-
2 antagonism
-
P.M. Vanhoutte, P.R. Saxena, R. Paoletti, N. Brunello, & A.S. Jackson. Dordrecht: Kluwer Academic Publishers
-
2 antagonism. Vanhoutte P.M., Saxena P.R., Paoletti R., Brunello N., Jackson A.S. Serotonin From Cell Biology to Pharmacology and Therapeutics . 1993;263-276 Kluwer Academic Publishers, Dordrecht.
-
(1993)
Serotonin: From Cell Biology to Pharmacology and Therapeutics
, pp. 263-276
-
-
Svensson, T.H.1
Nomikos, G.G.2
Andersson, J.L.3
-
40
-
-
0025026110
-
Suppression of conditioned avoidance behavior by the local application of (-)sulpiride into the ventral, but not the dorsal, striatum of the rat
-
Wadenberg M.-L., Ericson E.L., Magnusson O., Ahlenius S. Suppression of conditioned avoidance behavior by the local application of (-)sulpiride into the ventral, but not the dorsal, striatum of the rat. Biol Psychiatry. 28:1990;297-307.
-
(1990)
Biol Psychiatry
, vol.28
, pp. 297-307
-
-
Wadenberg, M.-L.1
Ericson, E.L.2
Magnusson, O.3
Ahlenius, S.4
-
41
-
-
0027466856
-
Potency mismatch for behavioral and biochemical effects by dopamine receptor antagonists: Implications for the mechanism of action of clozapine
-
Wadenberg M.-L., Ahlenius S., Svensson T.H. Potency mismatch for behavioral and biochemical effects by dopamine receptor antagonists Implications for the mechanism of action of clozapine . Psychopharmacology. 110:1993;273-279.
-
(1993)
Psychopharmacology
, vol.110
, pp. 273-279
-
-
Wadenberg, M.-L.1
Ahlenius, S.2
Svensson, T.H.3
|